Contents

21 Varicella (chickenpox)

References

  1. Lopez AS, Zhang J, Brown C, et al. 2011. Varicella-related hospitalizations in the United States, 2000–2006: the 1-dose varicella vaccination era. Pediatrics 127(2). DOI: 10.1542/peds.2010-0962 (accessed 19 December 2012).
  2. Shah S, Wood SM, Luan X, et al. 2010. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatric Infectious Disease Journal 29(3): 199–204.
  3. Khandaker G, Marshall H, Peadon E, et al. 2011. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Archives of Disease in Childhood 96(5). DOI: 10.1136/adc.2010.206037 (accessed 19 December 2012).
  4. Jumaan AO, Yu O, Jackson LA, et al. 2005. Incidence of herpes zoster, before and after varicella vaccination associated decreases in the incidence of varicella, 1992–2002. Journal of Infectious Diseases 191(12): 2002–7.
  5. Reynolds MA, Chaves SS, Harpaz R, et al. 2008. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. Journal of Infectious Diseases 197(Suppl 2). DOI: 10.1086/522162 (accessed 24 November 2013).
  6. Hales C, Harpaz R, Joesoef R, et al. 2013. Examination of links between herpes zoster incidence and childhood varicella vaccination. Annals of Internal Medicine 159(11): 739–45.
  7. Carville KS, Riddell MA, Kelly HA. 2010. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine 28(13): 2532–8.
  8. Leung J, Harpaz R, Molinari N-A, et al. 2011. Herpes zoster incidence among insured persons in the United States, 1993–2006: evaluation of impact of varicella vaccination. Clinical Infectious Diseases 52(3): 332–40.
  9. Centers for Disease Control and Prevention. 2007. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report: Recommendations and Reports 56(RR-4): 1–40.
  10. Wen S, Miles F, McSharry B, et al. 2013. Varicella in a paediatric intensive care unit: 10 year review from Starship Children’s Hospital, New Zealand. Journal of Paediatrics and Child Health. DOI: 10.1111/jpc.12473 [Epub before print] (accessed 30 December 2013).
  11. Pozza F, Piovesan C, Russo F, et al. 2011. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy. Vaccine 29(51): 9480–7.
  12. Chang L-Y, Huang L-M, Chang I-S, et al. 2011. Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan. BMC Infectious Diseases 11. URL: www.biomedcentral.com/1471-2334/11/352 (accessed 24 October 2013).
  13. Siedler A, Arndt U. 2010. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Eurosurveillance 15(13). URL: www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19530 (accessed 19 December 2012).
  14. Tan B, Bettinger J, McConnell A. 2012. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000–2008. Pediatric Infectious Disease Journal 31(9): 956–63.
  15. Committee on Infectious Diseases. 2007. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2 dose varicella immunization schedule (Reaffirmed July 2010). Pediatrics 120(1): 221–31.
  16. Marin M, Meissner C, Seward J. 2008. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 122(3): e744–51.
  17. Gershon A, Takahashi M, Seward JF. 2013. Varicella vaccine. In: Plotkin SA, Orenstein WA, Offit PA (eds). Vaccines (6th edition): Elsevier Saunders.
  18. Halperin SA, Ferrera G, Scheifele D, et al. 2009. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age. Vaccine 27(20): 2701–6.
  19. Ministry of Health. 2012. National Guidelines for Vaccine Storage and Distribution. URL: www.health.govt.nz/publication/national-guidelines-vaccine-storage-and-distribution-2012
  20. Reid S. 2012. The further and future evolution of the New Zealand Immunisation Schedule. New Zealand Medical Journal 125(1354): 86–99.
  21. LaRussa P, Steinberg S, Gershon A. 1996. Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. Journal of Infectious Diseases 174(Suppl 3): S320–3.
  22. Son M, Shapiro ED, LaRussa P, et al. 2010. Effectiveness of varicella vaccine in children infected with HIV. Journal of Infectious Diseases 201(12): 1806–10.
  23. Holmes C, Iglar KT, McDowell BJ, et al. 2004. Predictive value of a self-reported history of varicella infection in determining immunity in adults. Canadian Medical Association Journal 171(10): 1195–6.
  24. American Academy of Pediatrics. 2012. Varicella-zoster infections. In: Pickering LK, Baker CJ, Kimberlin DW, et al (eds). Red Book: 2012 report of the Committee on Infectious Diseases (29th). Elk Grove Village, IL: American Academy of Pediatrics.
  25. Centers for Disease Control and Prevention. 2010. Use of combination measles, mumps, rubella and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report: Recommendations and Reports 59(RR3). URL: http://www.cdc.gov/mmwr/pdf/rr/rr5903.pdf (accessed 12 September 2013).
  26. Centers for Disease Control and Prevention. 2012. FDA approval of an extended period for administering VariZIG for postexposure prophylaxis of varicella. Morbidity and Mortality Weekly Report 61(12). URL: www.cdc.gov/mmwr/pdf/wk/mm6112.pdf (accessed 7 October 2013).
  27. Centers for Disease Control and Prevention. 2013. Updated recommendations for use of VariZIG – United States, 2013. Morbidity and Mortality Weekly Report 62(28). URL: www.cdc.gov/mmwr/pdf/wk/mm6228.pdf (accessed 24 October 2013).
  28. Watson B, Steward J, Yang A, et al. 2000. Post exposure effectiveness of varicella vaccine. Pediatrics 105(1): 84–88.
  29. ​Heymann DL (ed). 2008. Control of Communicable Diseases Manual (19th edition). Washington DC: American Public Health Association.